EGIDI, MARIA FRANCESCA
 Distribuzione geografica
Continente #
NA - Nord America 8.529
AS - Asia 3.200
EU - Europa 2.192
SA - Sud America 573
AF - Africa 197
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 1
Totale 14.702
Nazione #
US - Stati Uniti d'America 8.288
CN - Cina 1.073
SG - Singapore 834
SE - Svezia 796
HK - Hong Kong 677
BR - Brasile 464
IT - Italia 446
BG - Bulgaria 308
VN - Vietnam 255
DE - Germania 199
CA - Canada 193
RU - Federazione Russa 128
SN - Senegal 108
TR - Turchia 99
GB - Regno Unito 89
UA - Ucraina 60
KR - Corea 52
AT - Austria 50
IN - India 46
AR - Argentina 44
BD - Bangladesh 32
CI - Costa d'Avorio 32
JP - Giappone 29
FI - Finlandia 26
EC - Ecuador 22
MX - Messico 22
ZA - Sudafrica 21
BE - Belgio 18
ID - Indonesia 15
IQ - Iraq 15
FR - Francia 14
DK - Danimarca 13
TW - Taiwan 13
PY - Paraguay 10
TN - Tunisia 10
JM - Giamaica 9
PK - Pakistan 9
UY - Uruguay 9
UZ - Uzbekistan 9
VE - Venezuela 9
AU - Australia 8
SA - Arabia Saudita 8
ES - Italia 7
MA - Marocco 7
PL - Polonia 7
AE - Emirati Arabi Uniti 6
BB - Barbados 6
KE - Kenya 6
CO - Colombia 5
LT - Lituania 5
EG - Egitto 4
PE - Perù 4
SK - Slovacchia (Repubblica Slovacca) 4
AZ - Azerbaigian 3
CL - Cile 3
CZ - Repubblica Ceca 3
DZ - Algeria 3
JO - Giordania 3
PS - Palestinian Territory 3
PT - Portogallo 3
RO - Romania 3
AL - Albania 2
AM - Armenia 2
BO - Bolivia 2
CH - Svizzera 2
CR - Costa Rica 2
HU - Ungheria 2
LK - Sri Lanka 2
MY - Malesia 2
NG - Nigeria 2
NL - Olanda 2
NZ - Nuova Zelanda 2
TH - Thailandia 2
BS - Bahamas 1
BT - Bhutan 1
BY - Bielorussia 1
CG - Congo 1
DM - Dominica 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
GD - Grenada 1
GE - Georgia 1
GL - Groenlandia 1
GR - Grecia 1
HN - Honduras 1
IL - Israele 1
KG - Kirghizistan 1
KH - Cambogia 1
KW - Kuwait 1
KZ - Kazakistan 1
LB - Libano 1
LU - Lussemburgo 1
LV - Lettonia 1
MT - Malta 1
MU - Mauritius 1
NI - Nicaragua 1
NP - Nepal 1
PH - Filippine 1
QA - Qatar 1
SC - Seychelles 1
Totale 14.698
Città #
Woodbridge 1.200
Fairfield 952
Ashburn 785
Houston 707
Hong Kong 672
Santa Clara 557
Singapore 496
Seattle 443
Ann Arbor 406
Chandler 391
Wilmington 346
Sofia 308
Cambridge 307
Beijing 277
Shanghai 273
Dallas 269
New York 194
Ottawa 161
Des Moines 152
Boardman 135
Princeton 132
Lawrence 130
Medford 126
Dakar 108
Nanjing 95
Los Angeles 90
Milan 69
Dearborn 63
Istanbul 58
San Diego 57
Redondo Beach 52
Ho Chi Minh City 47
Dong Ket 44
Grafing 41
Vienna 41
Buffalo 37
São Paulo 37
Abidjan 32
Hanoi 29
Frankfurt am Main 28
Hefei 28
Kunming 28
Pisa 25
Florence 24
Serra 24
Nanchang 21
Rio de Janeiro 21
Izmir 20
Falls Church 19
Guangzhou 19
Munich 18
Brussels 17
London 17
Lucca 17
Tokyo 17
Hebei 16
Quanzhou 15
Changsha 14
Jiaxing 14
Copenhagen 13
Kocaeli 13
Shenyang 13
Curitiba 12
Phoenix 12
Chicago 11
Fuzhou 11
Toronto 11
Johannesburg 10
Chennai 9
Montevideo 9
Turku 9
Belo Horizonte 8
Boston 8
Brasília 8
Chengdu 8
Jacksonville 8
Montreal 8
Quito 8
Tashkent 8
Bremen 7
Haiphong 7
Hangzhou 7
Norwalk 7
Nuremberg 7
Brooklyn 6
Chongqing 6
Da Nang 6
Denver 6
Guayaquil 6
Kingston 6
Lancaster 6
Manchester 6
Nairobi 6
Poplar 6
Rome 6
San Jose 6
Washington 6
Xiamen 6
Bridgetown 5
Buenos Aires 5
Totale 11.047
Nome #
Approccio incrementale di inizio dialisi: emodialisi bisettimanale, o monosettimanale associata a dieta ipoproteica-ipofosforica? [Incremental approach to hemodialysis: twice a week, or once weekly hemodialysis combined with low-protein low-phosphorus diet?] 259
Nephrolithiasis and hypertension: possible links and clinical implications. 233
Long-Term (5 Years) Efficacy and Safety of Pancreas Transplantation Alone in Type 1 Diabetic Patients 191
Transplantation of the pancreas 182
The extra-phosphate intestinal load from medications: is it a real concern? 182
Nutritional support in the tertiary care of patients affected by chronic renal insufficiency: Report of a step-wise, personalized, pragmatic approach 172
Outcomes of African-American kidney-transplant recipients treated with sirolimus, tacrolimus, and corticosteroids 164
Blood pressure phenotype reproducibility in CKD outpatients: a clinical practice report 161
Increase in endogenous glucose production with SGLT2 inhibition is attenuated in individuals who underwent kidney transplantation and bilateral native nephrectomy 161
Nutrition and physical activity in CKD patients. 160
Autoimmune hemolytic anemia in a cadaveric renal transplant recipient treated with cyclosporine 154
"Dietaly": practical issues for the nutritional management of CKD patients in Italy. 149
Improving results in solitary pancreas transplantation with portal-enteric drainage, thymoglobin induction, and tacrolimus/mycophenolate mofetil-based immunosuppression 144
Vitamin D status and cholecalciferol supplementation in chronic kidney disease patients: An Italian cohort report 143
Renal Involvement in IgG4-Related Disease: From Sunlight to Twilight 141
Ciclosporin in cadaveric renal transplants 140
Renal allograft loss as the result of polyomavirus interstitial nephritis after simultaneous kidney-pancreas transplantation: results with kidney retransplantation 139
Evolution in pancreas transplantation techniques: simultaneous kidney-pancreas transplantation using portal-enteric drainage without antilymphocyte induction 137
Prolactin, thymulin and zinc in chronic hemodialysis: effect of renal transplant 135
Prevention and management of hyperglycemia after pancreas transplantation 135
Risk factors for relapse and long-term outcome of idiopathic retroperitoneal fibrosis 135
Fine-needle aspiration biopsy in renal transplantation: a review of cytologic features 134
A randomized controlled trial to evaluate the effect of glycemic control on renal transplantation outcomes 133
Ciclosporin alone or associated with steroid for immunosuppression of cadaveric renal transplants? 133
Posttransplant quality of life: a decade of descriptive studies leading to practice interventions 133
Long-term experience with simultaneous kidney-pancreas transplantation with portal-enteric drainage and tacrolimus/mycophenolate mofetil-based immunosuppression 133
Comparison of azathioprine and mycophenolate mofetil in pancreas transplantation 131
A 9-year experience with 126 pancreas transplants with portal enteric drainage 130
Cyclosporine in cadaveric renal transplantation 129
Serum lipase as a marker for pancreatic allograft rejection 129
Limited benefits of induction with monoclonal antibody to interleukin-2 receptor in combination with tacrolimus, mycophenolate mofetil, and steroids in simultaneous kidney-pancreas transplantation 128
Allograft pancreatectomy after pancreas transplantation with systemic-bladder versus portal-enteric drainage 126
Comparison of efficacy of induction therapy in low immunologic risk African-American kidney transplant recipients 126
Combined simultaneous kidney/bone marrow transplantation 125
Human granulocytic ehrlichiosis in pancreas transplant recipients 125
Potential Differences in Kidney Allograft Outcomes Between Ethnicities When Converting to Sirolimus Base Immunosuppression 125
Spontaneous arterioenteric fistula after pancreas transplantation 124
Morphologic patterns of renal allograft rejection 124
Patterns of cytomegalovirus infection in simultaneous kidney-pancreas transplant recipients receiving tacrolimus, mycophenolate mofetil, and prednisone with ganciclovir prophylaxis 122
Three years of follow-up of bone marrow-augmented organ transplant recipients: the impact on donor-specific immune modulation 122
Simultaneous kidney-pancreas transplantation without antilymphocyte induction 120
Surveillance and monitoring of pancreas allografts 119
Conversion to sirolimus in solid organ transplantation: a single-center experience 119
Surgical complications after pancreas transplantation with portal-enteric drainage 119
Observations on the use of sirolimus and tacrolimus in high-risk renal transplant recipients 119
Long-term results of pancreas transplantation under tacrolimus immunosuppression 118
Are autoimmune diseases or glomerulonephritis affecting the development of panel-reactive antibodies in candidates for renal transplantation? 118
Controlled trial of two different methylprednisolone doses in cadaveric renal transplantation 118
Renal allograft outcomes in African American versus Caucasian transplant recipients in the tacrolimus era 118
Efficacy of induction therapy on acute rejection and graft outcomes in African American kidney transplantation 118
Clinical utility of histological features of polyomavirus allograft nephropathy 118
Risk factors and consequences of delayed graft function in deceased donor renal transplant patients receiving antithymocyte globulin induction 117
Enteric-drained pancreas transplants monitored by fine-needle aspiration biopsy 117
Augmentation of chimerism with perioperative donor bone marrow infusion in organ transplant recipients: A 44 month follow-up 117
Different methods to manage dry weight in hemodialysis patients 116
Serum lipase as a marker for pancreatic allograft rejection 115
Simultaneous kidney-pancreas transplant with systemic-enteric versus portal-enteric drainage 115
Experience with Portal-Enteric Pancreas Transplantation at the University of Tennessee-Memphis 115
Home blood pressure measurement as a systematic tool for clinical practice in CKD patients: A real-world picture 115
Initial clinical experience with interleukin-2 receptor antagonist induction in combination with tacrolimus, mycophenolate mofetil and steroids in simultaneous kidney-pancreas transplantation 114
Outcomes of simultaneous kidney-pancreas transplantation in African-American recipients: a case-control study 114
Posttransplant lymphoproliferative disorders: single center experience 114
Effects of different anti-rejection treatments on lymphocyte subsets in renal transplantation 113
A prospective comparison of simultaneous kidney-pancreas transplantation with systemic-enteric versus portal-enteric drainage 113
Approaches to Minimize Delayed Graft Function in Renal Transplantation 113
An ideal nondiabetogenic, nonnephrotoxic immunosuppressive protocols for pancreas transplantation 112
Comparison of sirolimus-based calcineurin inhibitor-sparing and calcineurin inhibitor-free regimens in cadaveric renal transplantation 112
Experience with portal-enteric pancreas transplantation at the University of Tennessee, Memphis 112
Surgical complications in 123 consecutive pancreas transplant recipients: comparison of bladder and enteric drainage 112
Use of tocilizumab in amyloid a nephropathy associated with Sweet syndrome: a case report and literature review 112
Fine Needle Aspiration Biopsy in Kidney and Pancreas Transplantation 111
Thymoglobulin for induction or rejection therapy in pancreas allograft recipients: a single centre experience 111
Role of surveillance biopsies in monitoring recipients of pancreas alone transplants 111
Correlation between fine-needle aspiration biopsy and renal biopsy in renal transplantation 110
Polyomavirus in kidney and kidney-pancreas transplant recipients 110
Long-term outcomes in simultaneous kidney-pancreas transplant recipients with portal-enteric versus systemic-bladder drainage 110
Proteinuria is a late-onset adverse event in patients treated with cabozantinib 110
Pancreas transplantation with enteric drainage under tacrolimus induction therapy 109
Renal fine-needle biopsy 108
Medical Management After Pancreas Transplantation 107
Pancreas transplantation without antibody therapy 107
The importance of early prevention of renal dysfunction in liver transplant recipients 107
En bloc pancreas and kidney transplantation in a patient with limited vascular access 106
The role of fine needle aspiration biopsy in clinical transplantation 106
Long-term outcomes in simultaneous kidney-pancreas transplant recipients with portal-enteric versus systemic-bladder drainage 105
Can preemptive cytomegalovirus monitoring be as effective as universal prophylaxis when implemented as the standard of care in patients at moderate risk? 105
Experience with Portal-Enteric Pancreas Transplantation at the University of Tennessee Memphis 105
Ganciclovir prophylaxis for cytomegalovirus infection in simultaneous kidney-pancreas transplant recipients receiving tacrolimus, mycophenolate mofetil, and prednisone 105
A search for optimizing corticosteroid administration to renal transplant patients 104
Lung ultrasound and BNP to detect hidden pulmonary congestion in euvolemic hemodialysis patients: a single centre experience 104
Observations regarding the use of sirolimus and tacrolimus in high-risk cadaveric renal transplantation 103
Pancreas Transplantation 103
Impact of hepatitis C virus status in pancreas transplantation: a case controlled study 102
Long-term follow-up of IgA mesangial nephropathy: clinico-histological study in 374 patients 102
A prospective comparison of systemic-bladder versus portal-enteric drainage in vascularized pancreas transplantation 101
Lifestyle behaviors affect cardiovascular risk status in men 1 year after kidney transplantation 101
A controlled prospective trial of triple therapy with low-dose azathioprine, cyclosporine, and methylprednisolone in renal transplantation 101
Management of the nephrotoxicity of cyclosporine in cadaveric renal transplant recipients 100
Tacrolimus without antilymphocyte induction therapy prevents pancreas loss from rejection in 123 consecutive patients 100
Clinical experience with ORTHOCLONE OKT3 in renal transplantation 98
Totale 12.483
Categoria #
all - tutte 45.080
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 45.080


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021493 0 0 0 0 0 37 26 45 103 81 52 149
2021/20221.503 41 100 27 122 274 199 32 92 69 33 114 400
2022/20231.619 244 213 130 104 132 280 24 135 277 7 66 7
2023/2024706 53 67 77 28 91 165 34 35 5 6 27 118
2024/20252.950 7 137 9 180 351 405 258 137 252 452 204 558
2025/20262.008 241 446 422 496 312 91 0 0 0 0 0 0
Totale 15.004